Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126743461 | 12674346 | 1 | I | 20151023 | 20151202 | 20160822 | 20160822 | PER | US-FRI-1000081488 | FOREST | 0.00 | F | Y | 0.00000 | 20160822 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126743461 | 12674346 | 1 | PS | SAPHRIS | ASENAPINE MALEATE | 1 | Sublingual | U | 22117 | TABLET | |||||||||
| 126743461 | 12674346 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | N | 0 | |||||||||||
| 126743461 | 12674346 | 3 | SS | ABILIFY | ARIPIPRAZOLE | 1 | N | 0 | |||||||||||
| 126743461 | 12674346 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | N | 0 | TABLET | ||||||||||
| 126743461 | 12674346 | 5 | SS | REXULTI | BREXPIPRAZOLE | 1 | 0.5 MG | N | U | BKS00115A | 0 | .5 | MG | QD | |||||
| 126743461 | 12674346 | 6 | SS | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | U | 0 | 20 | MG | |||||||||
| 126743461 | 12674346 | 7 | SS | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | SPLIT IT IN HALF TO GET 10 MG | U | 0 | ||||||||||
| 126743461 | 12674346 | 8 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | .5 | MG | ||||||||||
| 126743461 | 12674346 | 9 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 126743461 | 12674346 | 10 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | 0 | 10 | MG | ||||||||||
| 126743461 | 12674346 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | 20 | MG | TABLET | |||||||||
| 126743461 | 12674346 | 12 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126743461 | 12674346 | 1 | Product used for unknown indication |
| 126743461 | 12674346 | 2 | Bipolar disorder |
| 126743461 | 12674346 | 5 | Bipolar disorder |
| 126743461 | 12674346 | 8 | Psychomotor hyperactivity |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126743461 | 12674346 | Anger | |
| 126743461 | 12674346 | Disturbance in attention | |
| 126743461 | 12674346 | Euphoric mood | |
| 126743461 | 12674346 | Fatigue | |
| 126743461 | 12674346 | Feeling abnormal | |
| 126743461 | 12674346 | Feeling jittery | |
| 126743461 | 12674346 | Hyperphagia | |
| 126743461 | 12674346 | Hypomania | |
| 126743461 | 12674346 | Impulsive behaviour | |
| 126743461 | 12674346 | Irritability | |
| 126743461 | 12674346 | Logorrhoea | |
| 126743461 | 12674346 | Mania | |
| 126743461 | 12674346 | Psychomotor hyperactivity | |
| 126743461 | 12674346 | Sedation | |
| 126743461 | 12674346 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126743461 | 12674346 | 2 | 2015 | 0 | ||
| 126743461 | 12674346 | 4 | 2015 | 0 | ||
| 126743461 | 12674346 | 5 | 20150921 | 2015 | 0 |